ArticleBMC gastroenterology2022

Comparative effectiveness of second-line biological therapies for ulcerative colitis and Crohn's disease in patients with prior failure of anti-tumour necrosis factor treatment.

Hye Kyung Hyun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.